S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
Log in
NASDAQ:LHCG

LHC Group Stock Forecast, Price & News

$210.62
-0.93 (-0.44 %)
(As of 01/15/2021 12:00 AM ET)
Add
Compare
Today's Range
$209.55
Now: $210.62
$214.27
50-Day Range
$195.65
MA: $210.03
$221.64
52-Week Range
$100.00
Now: $210.62
$236.81
Volume135,913 shs
Average Volume164,448 shs
Market Capitalization$6.65 billion
P/E Ratio64.02
Dividend YieldN/A
Beta0.46
LHC Group, Inc., a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company's Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services. Its Hospice Services segment provides pain and symptom management accompanied by palliative medication, emotional and spiritual support, inpatient and respite care, homemaker services, dietary counseling, family bereavement counseling, and social worker visits. The company's Home and Community-Based Services segment offers services, such as assistance with grooming, medication reminders, meal preparation, assistance with feeding, light housekeeping, respite care, transportation, and errand services to patients in their home or in a medical facility. Its Facility-Based Services segment serves patients suffering from respiratory failure, neuromuscular disorders, cardiac disorders, non-healing wounds, renal disorders, cancer, head and neck injuries, and mental disorders, as well as treats patients diagnosed with musculoskeletal impairments; and operates institutional pharmacy, a family health center, a rural health clinic, and a retail pharmacy, as well as offers physical therapy services. The company's Healthcare Innovations (HCI) Services segment provides strategic health management services to Accountable Care Organizations. As of December 31, 2019, it operated 553 home health services locations, 110 hospice locations, 107 community-based service locations, 11 long-term acute care hospitals with 13 locations, and 10 HCI locations. The company was founded in 1994 and is based in Lafayette, Louisiana.
LHC Group logo

MarketRank

Overall MarketRank

1.48 out of 5 stars

Medical Sector

388th out of 1,558 stocks

Home Health Care Services Industry

5th out of 8 stocks

Analyst Opinion: 1.4Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Home health care services
Sub-IndustryHealth Care Services
SectorMedical
Current SymbolNASDAQ:LHCG
CUSIP50187A10
Phone337-233-1307
Employees30,399

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.08 billion
Cash Flow$5.98 per share
Book Value$47.83 per share

Profitability

Net Income$95.73 million

Miscellaneous

Market Cap$6.65 billion
Next Earnings Date2/24/2021 (Estimated)
OptionableOptionable
$210.62
-0.93 (-0.44 %)
(As of 01/15/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive LHCG News and Ratings via Email

Sign-up to receive the latest news and ratings for LHCG and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











LHC Group (NASDAQ:LHCG) Frequently Asked Questions

How has LHC Group's stock price been impacted by COVID-19?

LHC Group's stock was trading at $127.00 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, LHCG shares have increased by 65.8% and is now trading at $210.62.
View which stocks have been most impacted by COVID-19
.

Is LHC Group a buy right now?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LHC Group in the last twelve months. There are currently 2 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" LHC Group stock.
View analyst ratings for LHC Group
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than LHC Group?

Wall Street analysts have given LHC Group a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but LHC Group wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is LHC Group's next earnings date?

LHC Group is scheduled to release its next quarterly earnings announcement on Wednesday, February 24th 2021.
View our earnings forecast for LHC Group
.

How were LHC Group's earnings last quarter?

LHC Group, Inc. (NASDAQ:LHCG) released its earnings results on Wednesday, November, 4th. The health services provider reported $1.63 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.34 by $0.29. The health services provider had revenue of $530.68 million for the quarter, compared to analysts' expectations of $520.40 million. LHC Group had a return on equity of 9.71% and a net margin of 5.00%. LHC Group's revenue was up .4% on a year-over-year basis. During the same period in the prior year, the business posted $1.26 EPS.
View LHC Group's earnings history
.

What guidance has LHC Group issued on next quarter's earnings?

LHC Group updated its fourth quarter earnings guidance on Wednesday, November, 4th. The company provided earnings per share (EPS) guidance of $1.29-1.39 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.43. The company issued revenue guidance of $529-539 million, compared to the consensus revenue estimate of $535.12 million.

What price target have analysts set for LHCG?

8 brokers have issued twelve-month price targets for LHC Group's stock. Their forecasts range from $150.00 to $260.00. On average, they anticipate LHC Group's share price to reach $205.56 in the next year. This suggests that the stock has a possible downside of 2.4%.
View analysts' price targets for LHC Group
or view Wall Street analyst' top-rated stocks.

Who are some of LHC Group's key competitors?

What other stocks do shareholders of LHC Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other LHC Group investors own include Verizon Communications (VZ), NVIDIA (NVDA), The Home Depot (HD), Cisco Systems (CSCO), Visa (V), CVS Health (CVS), Johnson & Johnson (JNJ), Alibaba Group (BABA), Chevron (CVX) and Intel (INTC).

Who are LHC Group's key executives?

LHC Group's management team includes the following people:
  • Mr. Keith G. Myers, Co-Founder, CEO & Chairman (Age 61, Pay $905.48k)
  • Mr. Joshua L. Proffitt, Pres (Age 42, Pay $776.31k)
  • Mr. Nicholas Gachassin III, Exec. VP & Gen. Counsel (Age 53, Pay $535k)
  • Mr. Bruce D. Greenstein B.S., M.S., Exec. VP and Chief Strategy & Innovation Officer (Age 51, Pay $520.6k)
  • Mr. John L. Indest, Consultant & Independent Director (Age 68, Pay $101.5k)
  • Mr. Dale Gerard Mackel, Exec. VP, CFO & Treasurer (Age 56)
  • Ms. Kimberly S. Seymour, Sr. VP & Chief Accounting Officer (Age 43)
  • Mr. Mohammad Ali, Chief Information Officer
  • Mr. Marcus D. Macip, Exec. VP & Chief Admin. Officer
  • Ms. JoAnne Little, Sr. VP & Chief Compliance Officer

What is LHC Group's stock symbol?

LHC Group trades on the NASDAQ under the ticker symbol "LHCG."

Who are LHC Group's major shareholders?

LHC Group's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Scout Investments Inc. (0.23%), State of Alaska Department of Revenue (0.02%), Gradient Investments LLC (0.02%), Crossmark Global Holdings Inc. (0.01%), Sheets Smith Wealth Management (0.01%) and HGK Asset Management Inc. (0.01%). Company insiders that own LHC Group stock include Donald Dwayne Stelly, John L Indest, Joshua L Proffitt, Keith G Myers, Ronald T Nixon and W Earl Reed III.
View institutional ownership trends for LHC Group
.

Which institutional investors are selling LHC Group stock?

LHCG stock was sold by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, Gradient Investments LLC, and HGK Asset Management Inc..
View insider buying and selling activity for LHC Group
or view top insider-selling stocks.

Which institutional investors are buying LHC Group stock?

LHCG stock was purchased by a variety of institutional investors in the last quarter, including Scout Investments Inc., Diversified Trust Co, Sheets Smith Wealth Management, and Crossmark Global Holdings Inc..
View insider buying and selling activity for LHC Group
or or view top insider-buying stocks.

How do I buy shares of LHC Group?

Shares of LHCG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is LHC Group's stock price today?

One share of LHCG stock can currently be purchased for approximately $210.62.

How big of a company is LHC Group?

LHC Group has a market capitalization of $6.65 billion and generates $2.08 billion in revenue each year. The health services provider earns $95.73 million in net income (profit) each year or $4.47 on an earnings per share basis. LHC Group employs 30,399 workers across the globe.

What is LHC Group's official website?

The official website for LHC Group is www.lhcgroup.com.

How can I contact LHC Group?

LHC Group's mailing address is 901 HUGH WALLIS ROAD SOUTH, LAFAYETTE LA, 70508. The health services provider can be reached via phone at 337-233-1307 or via email at [email protected]

This page was last updated on 1/16/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.